Duophama Biotech Reports Resilient 2Q 2021 Performance
• 2Q PBT rises 4.2% to RM20.2 million as compared to previous corresponding quarter
• Declares interim dividend of 0.5 sen per share
• Increased Federal Government budget allocation for healthcare sector and extension of public sector supply
agreements to boost future earnings